Agarwal Ashok Kumar, Bansal Sonia, Nand Vidya
Senior Resident, Department of Medicine, Rajendra Institute of Medical Science (RIMS) , Ranchi, Jharkhand, India .
Microbiologist (Ex-Junior Resident), Department of Microbiology, Rajendra Institute of Medical Science (RIMS) , Ranchi, Jharkhand, India .
J Clin Diagn Res. 2014 Feb;8(2):73-6. doi: 10.7860/JCDR/2014/7154.4012. Epub 2014 Feb 3.
Tuberculosis kills 3.70 lakh patients in India every year,out of which 7-12 % are meningeal involvement. Delay in its diagnosis and initiation of treatment results in poor prognosis and squeal in up to 25% of cases. The aim of the present study is to look for a simple, rapid, cost effective, and fairly specific test in differentiating tubercular aetiology from other causes of meningitis. In the present study we measured the adenosine deaminase activity (ADA) in Cerebrospinal Fluid (CSF) of Tubercular Meningitis (TBM) and non-TBM patients.
Fifty six patients attending hospital with symptoms and signs of meningitis were selected and divided into three groups: tubercular, pyogenic, and aseptic meningitis, depending upon the accepted criteria. CSF was drawn and ADA estimated.
Out of 32 tubercular patients, 28 had CSF-ADA at or above the cut-off value while four had below. Out of 24 non-tuberculous patients (pyogenic and aseptic meningitis), two aseptic meningitis (AM) patient had ADA levels at or above the cut-off value while 22 had below this value. RESULTS of our study indicate that ADA level estimation in CSF is not only of considerable value in the diagnosis of TBM, CSF, and ADA level 10 U/L as a cut-off value with sensitivity 87.5% and specificity 83.33% and positive predictive value of the test was 87.5%.and 83.3% negative predictive value.
It can be concluded that ADA estimation in CSF is not only simple, inexpensive and rapid but also fairly specific method for making a diagnosis of tuberculous aetiology in TBM, especially when there is a dilemma of differentiating the tuberculous aetiology from non-tuberculous ones. For this reason ADA estimation in TBM may find a place as a routine investigation.
在印度,每年有37万结核病患者死亡,其中7%-12%有脑膜受累情况。诊断和开始治疗的延迟会导致预后不良,高达25%的病例会出现后遗症。本研究的目的是寻找一种简单、快速、经济有效且具有相当特异性的检测方法,以区分结核病因与其他脑膜炎病因。在本研究中,我们测量了结核性脑膜炎(TBM)患者和非TBM患者脑脊液(CSF)中的腺苷脱氨酶活性(ADA)。
选取56例有脑膜炎症状和体征的住院患者,根据公认标准分为三组:结核性、化脓性和无菌性脑膜炎。抽取脑脊液并测定ADA。
32例结核患者中,28例脑脊液ADA达到或高于临界值,4例低于临界值。24例非结核患者(化脓性和无菌性脑膜炎)中,2例无菌性脑膜炎(AM)患者ADA水平达到或高于临界值,22例低于此值。我们的研究结果表明,脑脊液中ADA水平的测定在结核性脑膜炎的诊断中不仅具有重要价值,以脑脊液ADA水平10 U/L作为临界值,敏感性为87.5%,特异性为83.33%,该检测的阳性预测值为87.5%,阴性预测值为83.3%。
可以得出结论,脑脊液中ADA的测定不仅简单、廉价、快速,而且是诊断结核性脑膜炎结核病因的相当特异的方法,特别是在区分结核病因与非结核病因存在两难情况时。因此,结核性脑膜炎中ADA的测定可能会成为一项常规检查。